Neoadjuvant immune-checkpoint inhibition is a promising emerging treatment approach for
patients with surgically resectable macroscopic stage III melanoma. The neoadjuvant setting …

Assessment of sentinel lymph node status is an important step in the evaluation of patients
with melanoma for both prognosis and therapeutic management. Pathologists have an …

Background In melanoma patients, surgical excision of the first draining lymph node, the
sentinel lymph node (SLN), is a routine procedure to evaluate lymphogenic metastases …

The prognostic value of sentinel node biopsy (SNB) is well established and SNB was
therefore adopted as a requirement for pathological staging of melanomas> 1 mm thick in …

Malignant melanoma was projected to have an incidence of> 99,000 cases in the United
States in 2022 and is one of the few cancers for which incidence is rising. 1 Current …

Abstract Background Melanomas< 0.8 mm in Breslow depth have less than a 5% risk for
nodal positivity. Nonetheless, nodal positivity is prognostic for this group. Early identification …

Background Sentinel lymph node biopsy is not routinely recommended for T1a cutaneous
melanoma due to the overall low risk of positivity. Prognostic factors for positive sentinel …

Background Regional lymph node metastasis (RLNM) occurs infrequently in patients with
soft tissue sarcoma (STS), although certain STS subtypes have a higher propensity for …

Simple Summary Sentinel lymph nodes are the first regional lymph nodes to receive lymph
fluid from the primary cancer, sentinel lymph node biopsy (SLNB) can detect occult nodal …

Simple Summary In this study, the treatment trends and survival among 557 patients with
sentinel lymph node biopsy (SLNB)-positive melanomas were analyzed. We have …